Declining China Dat...
Health Care: Drugs
Dynavax Technologies Corporation (DVAX: NASDAQ)
$2.53 0.01 | 0.40%
05/23/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -69.95M | -48.60M | -57.31M | -30.56M |
| Operating Gains/Losses | 8.00K | 20.00K | -36.00K | -4.14M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 8.52M | -8.53M | -106.00K | 5.51M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 126.00K | -289.00K | 643.00K | 781.00K |
| (Decrease) Increase In Other Current Liabilities | 1.92M | -2.17M | 3.38M | 762.00K |
| (Increase) Decrease In Other Working Capital | 1.36M | 3.22M | -12.76M | -31.86M |
| Other Non-Cash Items | 12.63M | 6.22M | 12.82M | 22.71M |
| Net Cash From Continuing Operations | -43.81M | -47.12M | -51.37M | -33.55M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -43.81M | -47.12M | -51.37M | -33.55M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 169.39M | 77.73M | 30.75M | 29.50M |
| Purchases of Property, Plant & Equipment | -2.93M | -1.14M | -420.00K | -377.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -206.15M | -111.20M | -80.84M | -14.29M |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -39.69M | -34.62M | -50.50M | 19.88M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 73.74M | 91.31M | 87.63M | 2.33M |
| Repayment of Long-Term Debt | -15.00M | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 307.00K | 132.00K | 0.00 | 19.73M |
| Net Cash From Financing Activities | 59.04M | 91.44M | 87.63M | 22.06M |
| Effect of Exchange Rate Changes | 118.00K | -218.00K | -23.00K | 235.00K |
| Net Change in Cash & Cash Equivalents | -24.34M | 9.49M | -14.27M | 8.62M |
Portfolios with DVAX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Usercdm1
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
- Contributor10 Stocks Boosting Little F...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
Latest DVAX Headlines from TheStreet
- 5 Stocks Under $5 to Watch 03.13.13 | 07:03 am
- Stocks Waver as Investors Eye Italian Election 02.25.13 | 02:02 pm
- Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejection 02.25.13 | 07:02 am
- Stock Futures Point to Higher Open 02.25.13 | 07:02 am
- Run-Up Trade Into Dynavax's FDA Approval Decision 02.13.13 | 07:02 am
- Dynavax Options Trade For Heplisav FDA Approval Decision 02.12.13 | 08:02 am
- Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics 02.08.13 | 06:02 am
- 5 Stocks Under $10 Ready to Soar Higher 02.07.13 | 01:02 pm
- 'Mad Money' Lightning Round: I'm Avoiding Controversial Coinstar 02.07.13 | 06:02 am
- Cramer's 'Mad Money' Recap: Pay Attention 02.06.13 | 07:02 pm
Press Releases for DVAX
Partner Headlines for DVAX
- Why Dynavax's HEPLISAV Is Likely To Be Approved: Impact On Future Vaccine Development - Seeking Alpha 11.21.12 | 09:11 am
- Mid-Day Markets Update: Markets Recover on Fiscal Cliff Meeting; Casino Stocks Continue to Ramp - Benzinga 11.16.12 | 01:11 pm
- Dynavax Gets Crushed After Advisory Committee Vote - Seeking Alpha 11.16.12 | 09:11 am
- Cramer's Mad Money - 10 Things To Watch In The Week Ahead (9/14/12) - Seeking Alpha 09.16.12 | 06:09 am
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
